ARCHIVES

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

This article is from The Cancer Letter archive.

Vol. 34 No. 36 | October 3, 2008

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

Cancer Act Renewals Marked By Disputes Over NCI Authorities

October 5, 1990

Mass. Congressman Pressed For $1.5 M Proton Beam Funds

August 18, 1989

In Brief: Groups agree On Mammography Screening: Money Bill Markups Due After July 4 Recess

June 23, 1989

DeVita Era At NCI One Of New Programs, Remarkable Stability

August 19, 1988

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

April 22, 1988